Skip to Main content Skip to Navigation
Journal articles

Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles

Abstract : Particle size distribution and stability are key attributes for the evaluation of the safety and efficacy profile of medical nanoparticles (Med-NPs). Measuring particle average size and particle size distribution is a challenging task which requires the combination of orthogonal high-resolution sizing techniques, especially in complex biological media. Unfortunately, despite its limitations, due to its accessibility, low cost, and easy handling, batch mode dynamic light scattering (DLS) is still very often used as the only approach to measure particle size distribution in the nanomedicine field. In this work the use of asymmetric flow field flow fractionation coupled to multiangle light scattering and dynamic light scattering detectors (AF4-MALS-DLS) was evaluated as an alternative to batch mode DLS to measure the physical properties of lipid-based nanoparticles. A robust standard operating procedure (SOPs) developed by the Nanomedicine Characterization Laboratory (EUNCL) was presented and tested to assess size stability, batch to batch consistency, and the behavior of the lipid-based nanoparticles in plasma. Orthogonal sizing techniques, such as transmission electron microscopy (TEM) and particle tracking analysis (PTA) measurements, were performed to support the results. While batch mode DLS could be applied as a fast and simple method to provide a preliminary insight into the integrity and polydispersity of samples, it was unsuitable to resolve small modifications of the particle size distribution. The introduction of nanoparticle sorting by field-flow fractionation coupled to online DLS and MALS allowed assessment of batch to batch variability and changes in the size of the lipid nanoparticles induced by the interaction with serum proteins, which are critical for quality control and regulatory aspects. In conclusion, if a robust SOP is followed, AF4-MALS-DLS is a powerful method for the preclinical characterization of lipid-based nanoparticles.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02160846
Contributor : Frank Thomas <>
Submitted on : Tuesday, November 24, 2020 - 9:39:53 AM
Last modification on : Tuesday, November 24, 2020 - 10:16:31 AM

File

Caputo et al. Mol Pharmaceutic...
Publication funded by an institution

Identifiers

Collections

Citation

Fanny Caputo, Amandine Arnould, Maria Bacia-Verloop, Wai-Li Ling, Emilie Rustique, et al.. Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles. Molecular Pharmaceutics, American Chemical Society, 2019, 16 (2), pp.756-767. ⟨10.1021/acs.molpharmaceut.8b01033⟩. ⟨hal-02160846⟩

Share

Metrics

Record views

340

Files downloads

41